Galectin-3 preserves renal tubules and modulates extracellular matrix remodeling in progressive fibrosis

被引:79
|
作者
Okamura, Daryl M. [1 ]
Pasichnyk, Katie
Lopez-Guisa, Jesus M.
Collins, Sarah
Hsu, Daniel K. [2 ]
Liu, Fu-Tong [2 ]
Eddy, Allison A.
机构
[1] Univ Washington, Seattle Childrens Res Inst, Div Nephrol, Dept Pediat, Seattle, WA 98105 USA
[2] Univ Calif Davis, Med Ctr, Div Res Dermatol, Sacramento, CA 95817 USA
基金
美国国家卫生研究院;
关键词
chronic kidney disease; nephron loss; matrix degradation; tubular apoptosis; defective tissue remodeling; GALECTIN-3/AGE-RECEPTOR-3 KNOCKOUT MICE; EXPERIMENTAL MURINE SCHISTOSOMIASIS; INTRACELLULAR COLLAGEN DEGRADATION; INTERSTITIAL FIBROSIS; PICROSIRIUS-POLARIZATION; OBSTRUCTIVE NEPHROPATHY; CELL-GROWTH; APOPTOSIS; RECEPTOR; INJURY;
D O I
10.1152/ajprenal.00326.2010
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Okamura DM, Pasichnyk K, Lopez-Guisa JM, Collins S, Hsu DK, Liu F, Eddy AA. Galectin-3 preserves renal tubules and modulates extracellular matrix remodeling in progressive fibrosis. Am J Physiol Renal Physiol 300: F245-F253, 2011. First published October 20, 2010; doi: 10.1152/ajprenal.00326.2010.-Renal tubular cell apoptosis is a critical detrimental event that leads to chronic kidney injury in association with renal fibrosis. The present study was designed to investigate the role of galectin-3 (Gal-3), an important regulator of multiple apoptotic pathways, in chronic kidney disease induced by unilateral ureteral obstruction (UUO). After UUO, Gal-3 expression significantly increased compared with basal levels reaching a peak increase of 95-fold by day 7. Upregulated Gal-3 is predominantly tubular at early time points after UUO but shifts to interstitial cells as the injury progresses. On day 14, there was a significant increase in TdT-mediated dUTP nick end labeling-positive cells (129%) and cytochrome c release (29%), and a decrease in BrdU-positive cells (62%) in Gal-3-deficient compared with wild-type mice. The degree of renal damage was more extensive in Gal-3-deficient mice at days 14 and 21, 35 and 21% increase in total collagen, respectively. Despite more severe fibrosis, myofibroblasts were significantly decreased by 58% on day 14 in the Gal-3-deficient compared with wild-type mice. There was also a corresponding 80% decrease in extracellular matrix synthesis in Gal-3-deficient compared with wild-type mice. Endo180 is a recently recognized receptor for intracellular collagen degradation that is expressed by interstitial cells during renal fibrogenesis. Endo180 expression was significantly decreased by greater than 50% in Gal-3-deficient compared with wild-type mice. Taken together, these results suggested that Gal-3 not only protects renal tubules from chronic injury by limiting apoptosis but that it may lead to enhanced matrix remodeling and fibrosis attenuation.
引用
收藏
页码:F245 / F253
页数:9
相关论文
共 50 条
  • [31] Erratum to: Galectin-3 in Cardiac Remodeling and Heart Failure
    Rudolf A. de Boer
    Lili Yu
    Dirk J. van Veldhuisen
    Current Heart Failure Reports, 2012, 9 (3) : 163 - 163
  • [32] Galectin-3 Participates in Cardiovascular Remodeling Associated With Obesity
    Martinez-Martinez, Ernesto
    Lopez-Andres, Natalia
    Jurado-Lopez, Raquel
    Rousseau, Elodie
    Visitacion Bartolome, Mara
    Fernandez-Celis, Amaya
    Rossignol, Patrick
    Islas, Fabian
    Antequera, Alfonso
    Prieto, Santiago
    Luaces, Maria
    Cachofeiro, Victoria
    HYPERTENSION, 2015, 66 (05) : 961 - 969
  • [33] Galectin-3 modulates postnatal subventricular zone gliogenesis
    Al-Dalahmah, Osama
    Soares, Luana Campos
    Nicholson, James
    Draijer, Swip
    Mundim, Mayara
    Lu, Victor M.
    Sun, Bin
    Tyler, Teadora
    Adorjan, Istvan
    O'Neill, Eric
    Szele, Francis G.
    GLIA, 2020, 68 (02) : 435 - 450
  • [34] GALECTIN-3 STRONGLY ASSOCIATES WITH RENAL FUNCTION, CARDIOMYOPATHY AND FIBROSIS IN PATIENTS WITH FABRY DISEASE
    Drechsler, Christiane
    De Boer, Rudolf
    Oder, Daniel
    Gutjahr-Lengsfeld, Lena
    Ueceyler, Nurcan
    Sommer, Claudia
    Wanner, Christoph
    Nordbeck, Peter
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 351 - 351
  • [35] Urinary Galectin-3 as a Novel Biomarker for the Prediction of Renal Fibrosis and Kidney Disease Progression
    Ou, Shuo-Ming
    Tsai, Ming-Tsun
    Chen, Huan-Yuan
    Li, Fu-An
    Lee, Kuo-Hua
    Tseng, Wei-Cheng
    Chang, Fu-Pang
    Lin, Yao-Ping
    Yang, Ruey-Bing
    Tarng, Der-Cherng
    BIOMEDICINES, 2022, 10 (03)
  • [36] Extracellular matrix remodeling in idiopathic pulmonary fibrosis
    Pardo, A
    Selman, M
    CHEST, 2001, 120 (01) : 77S - 77S
  • [37] Galectin-3 and myocardial fibrosis in nonischemic dilated cardiomyopathy
    Vergaro, Giuseppe
    Del Franco, Annamaria
    Giannoni, Alberto
    Prontera, Concetta
    Ripoli, Andrea
    Barison, Andrea
    Masci, Pier Giorgio
    Aquaro, Giovanni Donato
    Solal, Alain Cohen
    Padeletti, Luigi
    Passino, Claudio
    Emdin, Michele
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2015, 184 : 96 - 100
  • [38] The fibrosis marker galectin-3 and outcome in the general population
    de Boer, R. A.
    van Veldhuisen, D. J.
    Gansevoort, R. T.
    Kobold, A. C. Muller
    van Gilst, W. H.
    Hillege, H. L.
    Bakker, S. J. L.
    van der Harst, P.
    JOURNAL OF INTERNAL MEDICINE, 2012, 272 (01) : 55 - 64
  • [39] Prognostic value of galectin-3, a novel marker of fibrosis
    Dirk J. Lok
    Pieta W. Bruggink
    Peter van der Meer
    Clinical Research in Cardiology, 2010, 99 : 529 - 529
  • [40] Galectin-3 regulates myofibroblast activation and hepatic fibrosis
    Henderson, NC
    Mackinnon, AC
    Farnworth, SL
    Poirier, F
    Russo, FP
    Iredale, JP
    Haslett, C
    Simpson, KJ
    Sethi, T
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (13) : 5060 - 5065